Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

Pexidartinib often causes liver issues and fatigue, especially in women.

COVID-19 affects multiple body systems, not just the lungs.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Early recognition and tailored treatment are crucial for managing overlapping systemic lupus erythematosus and systemic sclerosis.

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

Pandemic stress worsens hair loss and skin issues, suggesting combined mental and skin care treatments.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

Hair transplantation is an effective hair loss treatment with two main techniques, requires careful planning, and can improve beard and eyebrows appearance.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

Scalp cooling reduces hair loss during chemotherapy but doesn't help hair regrow after.

Telogen effluvium is common after symptomatic COVID-19, especially in young females, and may be linked to nutritional deficiencies.

New understanding and treatments for hair loss are improving, but more research is needed.

COVID-19 can harm male fertility by reducing sperm stem cells and damaging testicular function.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

In 2021, JAMA Dermatology published significant findings on skin conditions post-COVID vaccination, melanoma surveillance, atopic dermatitis treatments, and confirmed that sun protection does not harm bone health.

Nearly 20% of recovered COVID-19 patients have skin issues, with hair loss and rashes being common.

The conference emphasized innovative solutions for global challenges, including disaster architecture, education, health, and economic impacts.

Long-term use of calcineurin inhibitors in transplant patients can cause hormone issues that can be managed with proper care.

Minoxidil helps hair regrow faster in stress-related hair loss.

Homeopathy helped a woman regrow hair and feel emotionally better after stress-related hair loss.

Long COVID patients may have hormonal imbalances linked to their symptoms.

Long COVID can cause long-lasting symptoms, but vaccination and early treatment can help prevent it.

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.

Some men experience persistent sexual, neurological, and psychological symptoms after stopping finasteride, but evidence of permanent damage is inconclusive.

COVID-19 may cause hair loss, especially in young adults.

Long COVID recovery is hindered by smoking, with hair loss being a difficult symptom to treat.